{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T19:53:53Z","timestamp":1724529233622},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,26]],"date-time":"2015-03-26T00:00:00Z","timestamp":1427328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s40360-015-0002-4","type":"journal-article","created":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T07:24:23Z","timestamp":1427268263000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Anti-malarial prescribing practices in Sudan eight years after introduction of artemisinin-based combination therapies and implications for development of drug resistance"],"prefix":"10.1186","volume":"16","author":[{"given":"Abeer Abuzeid Atta","family":"Elmannan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid Abdelmutalab","family":"Elmardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yassir Ali","family":"Idris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M","family":"Spector","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahid Abdelgadir","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elfatih Mohamed","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,26]]},"reference":[{"key":"2_CR1","volume-title":"Anti-malarial drug combination therapy: report of a WHO technical consultation","author":"World Health Organization","year":"2001","unstructured":"World Health Organization. Anti-malarial drug combination therapy: report of a WHO technical consultation. Geneva, Switzerland: World Health Organization; 2001."},{"key":"2_CR2","unstructured":"World Health Organization. Guidelines for the treatment of malaria. Geneva. 2006. ISBN 92-4-154694-8."},{"key":"2_CR3","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI21682","volume":"113","author":"NJ White","year":"2004","unstructured":"White NJ. Anti-malarial drug resistance. J Clin Invest. 2004;113:1084\u201392.","journal-title":"J Clin Invest"},{"key":"2_CR4","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1056\/NEJMc0805011","volume":"359","author":"H Noedl","year":"2008","unstructured":"Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359:2619\u201320.","journal-title":"N Engl J Med"},{"key":"2_CR5","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/S0140-6736(12)60484-X","volume":"379","author":"AP Phyo","year":"2012","unstructured":"Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, et al. Emergence of artemisinin-resistant malaria on the Western border of Thailand: a longitudinal study. Lancet. 2012;379:1960\u20136.","journal-title":"Lancet"},{"key":"2_CR6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in plasmodium falciparum malaria. New Eng J Med. 2014;371:411\u201323.","journal-title":"New Eng J Med"},{"key":"2_CR7","series-title":"Results of WHO product testing of malaria RDTs","volume-title":"Malaria rapid diagnostic test performance","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. Malaria rapid diagnostic test performance, Results of WHO product testing of malaria RDTs. Geneva: World Health Organization; 2010."},{"key":"2_CR8","unstructured":"World Health Organization. Global plan for artemisinin resistance. [\n                    http:\/\/www.who.int\/malaria\/publications\/atoz\/artemisininresistance%20containment%202011.pdf\n                    \n                  ]"},{"key":"2_CR9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1475-2875-6-55","volume":"6","author":"M Meremikwu","year":"2007","unstructured":"Meremikwu M, Okomo U, Nwachukwu C, Oyo-Ita A, Eke-Njoku J, Okebe J, et al. Anti-malarial drug prescribing practice in private and public facilities in south-east Nigeria: a descriptive study. Malar J. 2007;6:55.","journal-title":"Malar J"},{"key":"2_CR10","unstructured":"Global malaria programme. Update on artemisinin resistance. (WHO, April 2012)."},{"key":"2_CR11","volume-title":"The world medicines situation","author":"WHO","year":"2004","unstructured":"WHO. The world medicines situation. Geneva: World Health Organization; 2004. \n                    http:\/\/apps.who.int\/medicinedocs\/pdf\/s6160e\/s6160e.pdf\n                    \n                  ."},{"key":"2_CR12","volume-title":"Guidelines for the treatment of malaria","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. Guidelines for the treatment of malaria. 2nd ed. Geneva: World Health Organization; 2010.","edition":"2"},{"key":"2_CR13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/sj.clpt.6100361","volume":"82","author":"MM Nyunt","year":"2007","unstructured":"Nyunt MM, Plowe CV. Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance. Clin Pharmacol Ther. 2007;82:601\u20135.","journal-title":"Clin Pharmacol Ther"},{"key":"2_CR14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1475-2875-4-41","volume":"4","author":"SB Elamin","year":"2005","unstructured":"Elamin SB, Malik EM, Abdelgadir T, Khamiss AH, Mohammed MM, Ahmed ES, et al. Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan. Malar J. 2005;4:41.","journal-title":"Malar J"},{"key":"2_CR15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1475-2875-5-65","volume":"5","author":"EM Malik","year":"2006","unstructured":"Malik EM, Mohamed TA, Elmardi KA, Mowien RM, Elhassan AH, Elamin SB, et al. From chloroquine to artemisinin-based combination therapy: the Sudanese experience. Malar J. 2006;5:65.","journal-title":"Malar J"},{"key":"2_CR16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2458-12-11","volume":"12","author":"TM Abdelgader","year":"2012","unstructured":"Abdelgader TM, Ibrahim AM, Elmardi KA, Githinji S, Zurovac D, Snow RW, et al. Progress towards implementation of ACT malaria case-management in public health facilities in the Republic of Sudan: a cluster-sample survey. BMC Public Health. 2012;12:11.","journal-title":"BMC Public Health"},{"key":"2_CR17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1475-2875-10-128","volume":"10","author":"KA Elmardi","year":"2011","unstructured":"Elmardi KA, Noor AM, Githinji S, Abdelgadir TM, Malik EM, Snow RW. Self-reported fever, treatment actions and malaria infection prevalence in the northern states of Sudan. Malar J. 2011;10:128.","journal-title":"Malar J"},{"key":"2_CR18","unstructured":"\u201cHome \u2013 Al-Gezira State\u201d. Sudan Tribune. 2003\u20132013. Retrieved March 19, 2013."},{"key":"2_CR19","unstructured":"WHO. How to investigate drug use in health facilities. Selected Drug Use Indicators - EDM Research Series No. 007. (1993)."},{"key":"2_CR20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1475-2875-8-2","volume":"8","author":"A Dodoo","year":"2009","unstructured":"Dodoo A, Fogg C, Asiimwe A, Nartey E, Kodua A, Tenkorang O, et al. Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy. Malar J. 2009;8:2.","journal-title":"Malar J"},{"key":"2_CR21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1475-2875-5-60","volume":"5","author":"EM Malik","year":"2006","unstructured":"Malik EM, Hanafi K, Ali SH, Ahmed ES, Mohamed KA. Treatment-seeking behaviour for malaria in children under five years of age: implication for home management in rural areas with high seasonal transmission in Sudan. Malar J. 2006;5:60. Malar J. 2006 Jul 22;5:60.","journal-title":"Malar J"},{"key":"2_CR22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.4269\/ajtmh.1995.53.581","volume":"53","author":"M Cot","year":"1995","unstructured":"Cot M, Hesran JY, Miailes P, Esveld M, Etya\u2019ale D, Breart G. Increase in birth weight following chloroquine chemoprophylaxis during the first pregnancy: results of a randomized trial in Cameroon. Am J Trop Med Hyg. 1995;53:581\u20135.","journal-title":"Am J Trop Med Hyg"},{"key":"2_CR23","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-3156.2006.01587.x","volume":"11","author":"D Zurovac","year":"2006","unstructured":"Zurovac D, Midia B, Ochola SA, English M, Snow RW. Microscopy and outpatient malaria case management among older children and adults in Kenya. Trop Med Int Health. 2006;11:432\u201340.","journal-title":"Trop Med Int Health"},{"key":"2_CR24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4269\/ajtmh.2004.71.525","volume":"5","author":"C Fogg","year":"2004","unstructured":"Fogg C, Bajunirwe F, Piola P, Biraro S, Grandesso F, Ruzagira E, et al. Adherence to a six-dose regimen of artemether-Lumefantrine for treatment of uncomplicatedPlasmodium falciparum malaria in Uganda. Am J Trop Med Hyg. 2004;5:525\u201335.","journal-title":"Am J Trop Med Hyg"},{"key":"2_CR25","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(05)66416-1","volume":"365","author":"P Piola","year":"2005","unstructured":"Piola P, Fogg C, Bajunirwe F, Biraro S, Grandesso F, Ruzagira E, et al. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparummalaria in Mbarara, Uganda: a randomised trial. Lancet. 2005;365:1467\u201373.","journal-title":"Lancet"},{"key":"2_CR26","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0140-6736(05)66417-3","volume":"365","author":"TK Mutabingwa","year":"2005","unstructured":"Mutabingwa TK, Anthony D, Heller A, Hallett R, Ahmed J, Drakeley C, et al. Amodiaquine alone, amodiaquine\u2009+\u2009sulfadoxine-pyrimethamine, amodiaquine\u2009+\u2009artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet. 2005;365:1474\u201380.","journal-title":"Lancet"},{"issue":"5","key":"2_CR27","doi-asserted-by":"crossref","first-page":"e35151","DOI":"10.1371\/journal.pone.0035151","volume":"7","author":"JM Spector","year":"2012","unstructured":"Spector JM, Agrawal P, Kodkany B, Lipsitz S, Lashoher A, Dziekan G, et al. Improving quality of care for maternal and newborn health: prospective pilot study of the WHO safe childbirth checklist program. PLoS One. 2012;7(5):e35151. doi:10.1371\/journal.pone.003515.","journal-title":"PLoS One"},{"key":"2_CR28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMsa0810119","volume":"360","author":"AB Haynes","year":"2009","unstructured":"Haynes AB, Weiser TG, Berry WR, Lipsitz SR, Breizat AH, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med. 2009;360:491\u20139.","journal-title":"N Engl J Med"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-015-0002-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40360-015-0002-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-015-0002-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-015-0002-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T22:43:23Z","timestamp":1553640203000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-015-0002-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,26]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["2"],"URL":"https:\/\/doi.org\/10.1186\/s40360-015-0002-4","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,26]]},"assertion":[{"value":"10 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"3"}}